Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

survival analysis

  • Open Access
    Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020
    Eleonora Feletto, Qingwei Luo, Anna Kelly, Marianne Weber, David Goldsbury, Katherine Barron, Karen Canfell and Xue Qin Yu
    Cancer Biology & Medicine August 2024, 21 (8) 703-711; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0177
  • You have access
    Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets
    Huanyu Zhao, Ruoyu Dang, Yipan Zhu, Baijian Qu, Yasra Sayyed, Ying Wen, Xicheng Liu, Jianping Lin and Luyuan Li
    Cancer Biology & Medicine September 2022, 19 (9) 1352-1374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0586
  • You have access
    The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
    Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang and Yingying Xu
    Cancer Biology & Medicine May 2022, 19 (5) 755-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0800
  • You have access
    Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
    Yue-Ya Li, Chan Zhou, Deng-Xia Yang, Jing Wang, Zhu-Jun Liu, Xin-Yue Wang and Kai Li
    Cancer Biology & Medicine June 2015, 12 (2) 117-125; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0012
  • You have access
    Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer
    Fang Wang, Gui-fang Guo, Hui-juan Qiu, Wen-zhuo He, Fei-fei Zhou, Xu-xian Chen, Pi-li Hu, Bei Zhang, Chen-xi Yin, Li Zhang and Liang-ping Xia
    Cancer Biology & Medicine March 2012, 9 (1) 38-43; DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.01.007

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire